PHONE: (514) 694 1212
FAX: (514) 694-7075
 |
CTSNet is sponsored in part by an educational
grant from |
 |
|
||
SurgiFrost 7
CRYOCATH TECHNOLOGIES INC.
|
|
16771 Ch. Ste-Marie |
|
CryoAblation preserves tissue and collagen matrix integrity with virtually no risk of PV stenosis. Intact endothelium minimizes risks of endocardial thrombus associated with heat-baed energy sources.
PDF Documents
PRODUCT FEATURES
- SurgiFrost 7 uses new Argon technology to rapidly achieve temperatures as cold as -160°C in 30 to 60 seconds.
- Short ablation times allow you to perform procedures in a timely manner
- Transmural linear lesions can be produced in an open heart, or on a closed beating heart, giving you more flexibilty to meet your patients' needs.
- Longer, more flexible hose stays clear of your line of vision.
- The 7 cm freezing segment can be configures to desired lenths and shapes for tailoring ablation lines; malleable probe shaft with adjustable insulation sleeve
- Transmural in 1 minute in open heart and 3 minutes in beating heart.
- CryoAdhesion allows lesion placement certainty and ability to manipulate heart tissue.
- Adjustable insulation sheath allows ablation zone between 1 to 70 mm.
- No burning or charring
- Malleable cryoablation segments easily shapes to heart structures.
In the USA for minimally invasive cardiac surgical procedures, including the treatment of cardiac arrythmias. 510(k) cleared.
In Europe for surgical procedures, including surgical treatment of cardiac arrhythmias.